市場調查報告書

神經調節設備的全球市場:各設備、應用、終端用戶、地區市場規模,佔有率,展望及機會分析

Neuromodulation Devices Market, By Device Type, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 942014
出版日期 內容資訊 英文 183 Pages
商品交期: 2-3個工作天內
價格
神經調節設備的全球市場:各設備、應用、終端用戶、地區市場規模,佔有率,展望及機會分析 Neuromodulation Devices Market, By Device Type, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年05月21日內容資訊: 英文 183 Pages
簡介

為了治療神經病變相關的脊髓損傷及肌肉無力使用電刺激的電療。這活化電脈衝,具有發送訊號到設備電極的特性。據此,脫極化發生,疼痛減輕,提高肌肉力量。各種電刺激設備,為管理疼痛治療肥胖等各種疾病而設計。

本報告提供全球神經調節設備市場調查,市場概要,各類型,各地區的市場趨勢,市場規模的變化與預測,市場成長、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與前提條件

    • 調查目的
    • 前提條件
    • 簡稱

第2章 市場展望

    • 報告概要
    • 市場定義和範圍
    • 摘要整理
    • 各設備類型市場
    • 各應用領域市場
    • 各終端用戶市場
    • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

    • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析
    • 主要趨勢
    • 技術進步
    • 法規方案

第4章 全球神經調節設備市場:各設備類型,(百萬美元)

    • 簡介
    • 市場佔有率分析(%)
    • 與前一年同期比較成長分析
    • 市場區隔趨勢
    • 脊髓刺激設備
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 市場區隔趨勢
    • 深部腦刺激設備
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 市場區隔趨勢
    • 薦椎神經刺激設備
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 市場區隔趨勢
    • 迷走神經刺激設備
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 市場區隔趨勢
    • 胃的電刺激設備
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 市場區隔趨勢

第5章 全球神經調節設備市場:各應用領域(百萬美元)

    • 簡介
    • 市場佔有率分析(%)
    • 與前一年同期比較成長分析
    • 市場區隔趨勢
    • 疼痛管理
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 神經及異動症的管理
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 肌肉骨骼障礙的管理
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 與代謝GIT管理
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 失禁管理
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 其他
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)

第6章 全球神經調節設備市場:各終端用戶(百萬美元)

    • 簡介
    • 市場佔有率分析(%)
    • 與前一年同期比較成長分析
    • 市場區隔趨勢
    • 醫院
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 專門診所
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 門診中心
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 其他
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)

第7章 全球神經調節設備市場:各地區(百萬美元)

    • 簡介
    • 市場佔有率分析(%)
    • 與前一年同期比較成長分析
    • 市場區隔趨勢
    • 北美
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 美國
    • 加拿大
    • 歐洲
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太地區
    • 南美
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他南美國家
    • 中東
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • GCC
    • 以色列
    • 其他中東
    • 非洲
    • 簡介
    • 市場規模與預測,及與前一年同期比較的成長率(百萬美元)
    • 北非
    • 中非
    • 南非

第8章 競爭情形

    • 企業簡介
    • Axonics Modulation Technologies,Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • ShiraTronics,Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Bioness, Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • LivaNova
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Neuronetics,Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Medtronic plc
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • St. Jude Medical
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Boston Scientific Corporation
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Cyberonics
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Nevro
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Integer Holdings Corporation
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
    • Uroplasty
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略

第9章 Section

    • 參考文件
    • 調查手法
    • 諮詢方式
目錄

Title:
Neuromodulation Devices Market, By Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices), By Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Restraints of the Global Neuromodulation Devices Market

Side effects and risks associated with the use of neuromodulation devices are expected to hinder growth of the global neuromodulation devices market.

Key features of the study:

  • This report provides in-depth analysis of the global neuromodulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global neuromodulation devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Axonics Modulation Technologies, Inc., ShiraTronics, Inc., Bioness, Inc., LivaNova, Neuronetics, Inc., Medtronic plc, St. Jude Medical, Boston Scientific Corporation, Cyberonics, Nevro, Integer Holdings Corporation, and Uroplasty
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Neuromodulation Devices Market, By Device Type:
    • Spinal Cord Stimulation Devices
    • Deep Brain Stimulation Devices
    • Sacral Nerve Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Gastric Electric Stimulation Devices
  • Global Neuromodulation Devices Market, By Application:
    • Pain Management
    • Neurological and Movement Disorder Management
    • Musculoskeletal Disorder Management
    • Metabolism & GIT Management
    • Incontinence Management
    • Others
  • Global Neuromodulation Devices Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Centers
    • Others
  • Global Neuromodulation Devices Market, By Geography:
    • North America
    • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
    • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
    • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
    • By Country:
  • U.S.
  • Canada
    • Europe
    • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
    • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
    • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
    • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
    • Asia Pacific
    • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
    • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
    • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
    • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
    • Latin America
    • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
    • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
    • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • Middle East:
    • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
    • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
    • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • Africa
    • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
    • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
    • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
    • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
    • Axonics Modulation Technologies, Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
    • ShiraTronics, Inc.
    • Bioness, Inc.
    • LivaNova
    • Neuronetics, Inc.
    • Medtronic plc
    • St. Jude Medical
    • Boston Scientific Corporation
    • Cyberonics
    • Nevro
    • Integer Holdings Corporation
    • Uroplasty

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Device Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Neuromodulation Devices Market, By Device Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Spinal Cord Stimulation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Deep Brain Stimulation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Sacral Nerve Stimulation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Vagus Nerve Stimulation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Gastric Electric Stimulation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

5. Global Neuromodulation Devices Market, By Application, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Neurological and Movement Disorder Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Musculoskeletal Disorder Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Metabolism & GIT Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Incontinence Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

6. Global Neuromodulation Devices Market, By End User, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Ambulatory Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

7. Global Neuromodulation Devices Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
    • Axonics Modulation Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • ShiraTronics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bioness, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • LivaNova
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Neuronetics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Medtronic plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • St. Jude Medical
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cyberonics
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Nevro
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Integer Holdings Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Uroplasty
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact